338 related articles for article (PubMed ID: 16575771)
1. [Neurotransmitters in Alzheimer's disease].
Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
[TBL] [Abstract][Full Text] [Related]
2. [New therapeutic options in Alzheimer's disease].
García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
[TBL] [Abstract][Full Text] [Related]
3. [Anticholinesterases in the treatment of Alzheimer's disease].
Gandía L; Alvarez RM; Hernández-Guijo JM; González-Rubio JM; de Pascual R; Rojo J; Tapia L
Rev Neurol; 2006 Apr 16-30; 42(8):471-7. PubMed ID: 16625509
[TBL] [Abstract][Full Text] [Related]
4. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.
Verhoeff NP
Expert Rev Neurother; 2005 Mar; 5(2):277-84. PubMed ID: 15853497
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer's disease and neurotransmitters].
Nakamura S
Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
[No Abstract] [Full Text] [Related]
7. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
[TBL] [Abstract][Full Text] [Related]
9. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
Sugimoto H
Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.
Gongadze N; Antelava N; Kezeli T; Okudjava M; Pachkoria K
Georgian Med News; 2008 Feb; (155):44-8. PubMed ID: 18401056
[TBL] [Abstract][Full Text] [Related]
12. Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.
Houghton PJ; Howes MJ
Neurosignals; 2005; 14(1-2):6-22. PubMed ID: 15956811
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!
Tabet N
Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic function and Alzheimer's disease.
Giacobini E
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
[TBL] [Abstract][Full Text] [Related]
15. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
Davidson M; Stern RG
Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
[TBL] [Abstract][Full Text] [Related]
16. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
Sheng SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
[TBL] [Abstract][Full Text] [Related]
17. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
[TBL] [Abstract][Full Text] [Related]
18. [Neurotransmitter anomalies in Alzheimer's disease].
Berger B
Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
[TBL] [Abstract][Full Text] [Related]
19. Potent beta-amyloid modulators.
García-Palomero E; Muñoz P; Usan P; Garcia P; Delgado E; De Austria C; Valenzuela R; Rubio L; Medina M; Martínez A
Neurodegener Dis; 2008; 5(3-4):153-6. PubMed ID: 18322376
[TBL] [Abstract][Full Text] [Related]
20. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Shinagawa S; Shigeta M
Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
